Root Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Root Financial Partners's VRTX Position: Q2 2026 in Review
Root Financial Partners increased its Vertex Pharmaceuticals (VRTX) stake by 55% in Q2 2026, buying an estimated $74.9K and bringing the position to 474 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #351.
Root Financial Partners first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Root Financial Partners held 474 shares of Vertex Pharmaceuticals worth $235K as of Q2 2026.
- Root Financial Partners bought 169 Vertex Pharmaceuticals shares in Q2 2026, an estimated $74.9K.
- Vertex Pharmaceuticals made up 0.01% of Root Financial Partners's portfolio in Q2 2026, its #351 holding.
- Root Financial Partners first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.